SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Guilford (GLFD) - Steadily Rising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: NeuroInvestment who wrote (125)10/11/1997 11:24:00 AM
From: tdinovo   of 496
 
Neuro,
I suppose you're right. I'm an engineer not a scientist so I'm certainly not in a position to contradict your assertion. Frankly, I am confident that between the fine technologists at Guilford and Amgen that the right choice will be made. I'm more interested in the time frame suggested in the JP analyst's report. Obviously, the sooner the choice is made, the sooner GLFD's coffers fill further. Nice thought, huh!

To all:

Has anyone heard anything further on the Taxol deal. Did it lapse October 1 or are negotiations still on-going. Neuro, did this deal come up in your conversation with GLFD executives?

Ted
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext